Information for Authors

The Journal of UrologyÒ contains 3 sections: Adult Urology, Pediatric lowercase letters. All abbreviations used in the table should be defined in an
Urology and Urological Survey. Original clinical and translational Abbreviations footnote.
research studies will be considered for publication in the Adult and Review Articles are to be prepared in the same format as an Original
Pediatric Urology Sections. Translational research manuscripts Clinical Article.
must have a clear and proximate translation to patient care, and Reporting Standards: At The Journal of UrologyÒ, we expect authors
only preclinical scientific studies that have the direct potential to to follow well-defined reporting standards to improve the reliability and
translate into new and improved standards of care will be reviewed. value of published health research and promote transparent and accurate
All communications concerning editorial matters should be sent to: reporting. These standards can be found at equator network (https://
The Journal of UrologyÒ www.equator-network.org). We also advocate for authors to follow best
Publications Department practices for reporting of adverse events such as Common Terminology
American Urological Association Criteria for Adverse Events (CTCAE), which is an internationally accepted
1000 Corporate Boulevard standard for defining and categorizing adverse events.
Linthicum, MD 21090 New Technology and Techniques feature high quality manuscripts
Telephone: (410) 689-3922, FAX: (410) 689-3906 that describe the innovative clinical application of new technology or
Email: [email protected] techniques in all disciplines of urology, and are designated as such by the
Editors. Addressing diagnosis or management of urological conditions, this
MANUSCRIPT SUBMISSION feature covers the categories of 1) cutting-edge technology, 2) novel/modified
Authors must submit their manuscripts through the Editorial Manager techniques, and 3) outcomes data derived from use of 1 and/or 2. The format
Web-based tracking system at https://www.editorialmanager.com/ju. The is the same as an Original Clinical Article, although fewer words are
site contains instructions and advice on how to use the system, guidance on preferred to allow more space for illustrations.
the creation/scanning and saving of electronic art, and supporting docu- JU Forum. The JU Forum is a feature for presentations of pertinent new
mentation. In addition to allowing authors to submit manuscripts on ideas, perspective on advances in the field, recommendations for novel stra-
the Web, the site allows authors to follow the progression of their manu- tegies, topics related to training and education, and discussion of relevant
script through the peer review process. Initial manuscripts can be submitted socioeconomic considerations that impact patient care. These concise com-
using any common scientific format, writing style, and reference list. mentaries should be no more than 1,500 words without graphics or 1,200
Accepted articles will be required to conform to JU formatting guidelines. words with a single table or illustration, with no more than 10 references. The
For potentially acceptable manuscripts, the period between preferred number of authors is 3 or fewer from no more than 2 separate in-
receipt of all reviews and when an editorial decision is made is stitutions, although exceptions can be made in special circumstances.
usually longer. Historical Articles. Articles provide a historical perspective on the
Original Clinical and Translational Research Articles: Authors development of the specialty of urology. The length should not exceed 1,200
must adhere to the CONSORT guidelines for clinical and randomized words with a single table or figure or 1,500 words with no visuals. No more
trials (http://www.consort-statement.org/downloads). Manuscripts should be than 10 references should be listed and no more than three authors should
arranged as follows: Title Page, Abstract, Introduction, Materials and be included in the byline.
Methods, Results, Discussion, Conclusions, References, Tables, Figure Letters to the Editor should be useful to urological practitioners. The
Captions. The title page should contain a concise, descriptive title, the length should not exceed 500 words and 5 references.
names, email addresses, and affiliations of all authors, and a brief descrip- Video Clips may be submitted for posting on The Journal website, and are
tive runninghead not to exceed 70 characters. Up to 5 key words should be subject to peer review. Video files must be compressed to the smallest possible size
typed at the bottom of the title page. These words must be National Library that still allows for high resolution and quality presentation. The size of each clip
of Medicine indexed MeSH (medical subject headings) terms, which can be should not exceed 40 MB. File size limitation is intended to ensure that end-users are
verified at https://ncbi.nlm.nih.gov/mesh; non-MeSH key words will not be able to download and view files in a reasonable time frame. If files exceed the spec-
printed. The abstract should not exceed 250 words and must conform to the ified size limitation, they will not be posted to the website and must be resubmitted.
following style: Purpose, Materials and Methods, Results and Conclusions.
JOURNAL ETHICS
Per Journal style, no abbreviations can be used in the abstract.
The Journal of UrologyÒ expects the highest ethical standards from their
References should not exceed 30 readily available citations for all authors, reviewers, and editors when conducting research, submitting papers,
articles (except Review Articles). Self-citations should be kept to a minimum. and throughout the peer review process. The Journal of UrologyÒ is listed
References should be cited by superscript numbers in the order they appear among those journals that follow the Recommendations for the Conduct,
in the text. References should include the names and initials of all authors if Reporting, Editing and Publication of Scholarly Work in Medical Journals of the
6 or fewer, or the first 3 authors and “et al” if more than 6. the complete title,
International Committee of Medical Journal Editors (ICMJE; http://www.icmje.
abbreviated journal name (italicized) according to the Index Medicus of the
org/recommendations/).
National Library of Medicine, year of publication, volume and issue number,
Plagiarism e Plagiarism is scientific misconduct and will be addressed
and page range.
as such. When plagiarism is detected at any time before publication, the
Example: Eastham JA, Boorjian SA, Kirkby E. Clinically localized prostate
editorial office will take appropriate action as directed by the standards set
cancer: AUA/ASTRO guideline. J Urol. 2022;208(3):505-507.
forth by the Committee on Publication Ethics (COPE). For additional in-
Reference formatting suggestions are available on PubMedÒ through the
“Cite” button for each article (select “AMA format”). formation, please visit http://www.publicationethics.org.
References to book chapters should include names and initials of the first Redundant or Duplicate Publication e A duplicate or redundant
6 chapter authors, chapter title, book title and edition, names and initials of submission is the same manuscript (or the same data) submitted to different
the first 6 book editors, publisher, volume number, chapter number, page journals at the same time, or that overlaps substantially with one already
range, and year of publication. References to electronic publications should published, in press, or in an electronic media submission. International
include type of medium, name of the website, date published (and updated, if copyright laws, ethical conduct, and cost-effective use of resources require
available), the URL, and date of accession. The statistical methods should be that readers can be assured that what they are reading is original. (ICMJE:
indicated and referenced; enough information should be presented to allow http://www.icmje.org/recommendations/browse/publishing-andeditorial-
an independent critical assessment of the data. issues/overlappingpublications.html)
Digital illustrations and tables should be kept to a necessary minimum Submitted manuscripts should not have been published or currently
and their information should not be duplicated in the text. No more than 10 il- submitted elsewhere. Duplicate publication will be grounds for prompt
lustrations should accompany the manuscript for clinical articles. Magnifications rejection of the submitted manuscript. If the editor was not aware of the
for photomicrographs should be supplied and graphs should be labeled clearly. violation and the article has been published, a notice of duplicate submission
Reference to illustrations, numbered with Arabic numerals, must be provided in and the ethical violation will be published.
the text and called out in numerical order. Blurry or unrecognizable illustrations Conflicts of Interest e At the point of submission, policy requires that
are not acceptable. Visit http://links.lww.com/ES/A42 for detailed instructions for each author reveals any financial interests or connections, direct or indirect,
digital art. The use of color is encouraged at no charge to the authors. or other situations that might raise the question of bias in the work reported
Tables should be numbered and referred to in the text in numerical order. or the conclusions, implications, or opinions stated, including pertinent
In general, they should present summarized rather than individual raw data. commercial or other sources of funding for the individual author(s) or for the
All data should be clearly described in the column or row headers, including associated department(s) or organization(s), personal relationships, or direct
units where applicable. If footnotes are needed, please use superscripted academic competition.

572 j www.auajournals.org/jurology
 INFORMATION FOR AUTHORS 573

If the manuscript is accepted, Conflict of Interest information will be communicated in a published statement.
Data Availability Statement e The Journal of UrologyÒ requires authors to include in any articles that report results derived from research data to include a
Data Availability Statement. The provision of a Data Availability Statement will be verified as a condition of publication. Data Availability Statements should
include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived data sets
analyzed or generated during the study. Where research data are not publicly available, there must be a statement in the manuscript along with any conditions
for accessing the data. Data Availability Statements must take one of the following forms (or a combination of more than one if required for multiple types of
research data):
 The data sets generated during and/or analyzed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO
DATA SETS].
 The data sets generated during and/or analyzed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but
are available from the corresponding author on reasonable request.
 The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
 Data sharing not applicable to this article as no data sets were generated or analyzed during the current study.
 All data generated or analyzed during this study are included in this published article [and its supplementary information files].
 The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were
used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and
with permission of [third party name].
Permissions to Reproduce Previously Published Material e For permissions to reproduce, please see the license under which the individual article has
been published. Articles published in The Journal of UrologyÒ are copyrighted by the society owner, American Urological Association Education and Research,
Inc. (AUA).
Patient Consent Forms e The protection of a patient’s right to privacy is essential. Please collect and keep copies of patients’ consent forms on which patients
or other subjects of your experiments clearly grant permission for the publication of photographs or other material that might identify them. If the consent form for
your research did not specifically include this, please obtain it or remove the identifying material.
A statement to the effect that such consent had been obtained must be included in the Materials and Methods section of your paper. The editors may request a
copy of any consent forms.
Ethics Committee Approval e All articles must include an ethics statement. For studies conducted on human participants you must state clearly that study
participants have provided written consent and/or informed consent from the study participants; please also look at the latest version of the Declaration of Helsinki.
Institutional Review Board, ethics committee, or ethical review board study approval (including IRB number) must be stated in the manuscript. If ethics clearance
was not necessary, or if there was any deviation from these standard ethical requests, please state why it was not required. Please note that the editors may ask you
to provide evidence of ethical approval. If you have approval from a National Drug Agency (or similar), please state this and provide details, as this can be
particularly useful when discussing the use of unlicensed drugs.
Author responsibilities e Manuscripts must be accompanied by a cover letter. The letter should include the complete address, telephone number, and
email address of the designated corresponding author. Only 1 author per article may serve as the corresponding author. The corresponding author is
responsible for providing the email addresses for all authors, indicating the source of extra institutional funding, in particular that provided by commercial
sources, and accuracy of the references and all statements made in their work, including changes made by the copy editor. The corresponding author also
certifies that, when applicable, a statement(s) has been included in the manuscript documenting Institutional Review Board, ethics committee, or ethical
review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use
committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; and animal
approved project number.
All clinical trials must be registered in a public trials registry at or before the time of first patient enrollment and the registration number provided as a condition
of consideration for publication.
It is the responsibility of every person listed as an author of an article published in The Journal of UrologyÒ to follow the practice and ethical guidelines set forth by
the International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-con-
tributors.html#two).
According to the ICJME, authorship is based on the following 4 criteria:
 Substantial contributions to the conception or design of the work, or the acquisition, analysis or interpretation of data for the work; AND
 Drafting the work or revising it critically for important intellectual content; AND
 Final approval of the version to be published; AND
 Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved.
All those designated as authors must meet ALL 4 criteria for authorship. Those who do meet ALL 4 criteria will be identified as authors and their names will be
printed in the byline of the article.
When a large, multicenter group or committee has conducted the work, the group should identify as authors only those individuals who fulfill ALL of the above
requirements and accept direct responsibility for the manuscript. The corresponding author must clearly indicate the preferred citation and identify all individual
authors as well as the group name. Contributors to the study who do not meet ALL 4 criteria of authorship will be acknowledged in an Appendix and identified as
Collaborators so their names can be indexed in MEDLINE. Examples of contributions that do not justify authorship are acquisition of funding, general supervision of
a research group, served as scientific advisors, critically reviewed the study proposal, collected data, provided and cared for study patients, and participated in
writing or technical editing of the manuscript.
Authors are expected to submit complete and correct manuscripts. Published manuscripts become the sole property of The Journal of UrologyÒ and copyright will
be taken out in the name of the American Urological Association Education and Research, Inc.
The electronic AUA Disclosure and Author Submission Requirement forms at the end of this document will be sent to each individual author of
acceptable manuscripts to be completed, signed, and returned electronically to [email protected]. Articles will not be published until all
completed forms are received.
Upon author request, all accepted NIH-funded articles will be deposited by the publisher to PubMed Central for public access 12 months after the
publication date.

EDITORIAL DECISION APPEALS

As is common practice for medical journals, when a paper is rejected from The Journal of UrologyÒ, there is no offer to reconsider a resubmitted version. Under
these circumstances, authors are strongly advised not to resubmit a revised version because it will be declined without further review. If the authors believe they
have a strong scientific case for reconsideration (if the referees have missed the point of the paper, for example), they can appeal the decision in writing. Written
appeals should be sent to the Editorial Office ([email protected]). Because of The Journal’s extreme space constraints and the large number of quality papers
under active consideration at all times, editors cannot assign a high priority to consideration of such appeals. The main grounds for a successful appeal for
reconsideration are if the author can identify a specific technical or other point of interest that had been missed by the referees and editors previously. Appeals
written in general or vague terms or containing arguments not relevant to the content of the particular manuscript are not likely to be successful. Manuscripts
cannot be submitted elsewhere while an appeal is being considered.
574 INFORMATION FOR AUTHORS

OPEN ACCESS
The American Urological Association journals offer a hybrid Open Access (OA) option to authors whose articles have been accepted for publication. Authors sub-
mitting work to The Journal of UrologyÒ will be given the opportunity to select the OA option at the revision stage of the peer review process, contingent upon acceptance
of the paper. This choice has no influence on the peer review and acceptance process. All articles are subject to the standard peer review process and will be accepted or
rejected based on their own merit.
Authors of accepted articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately
upon publication. OA articles will be freely available to read, download, and share from the time of publication.
The article processing charge for The Journal of UrologyÒ is $3,710 per article to be published under the Creative Commons Attribution-NonCommercial-No
Derivatives 4.0 International Public License (CC BY NC ND 4.0). This license allows readers to disseminate and reuse the article, as well as share and reuse the
scientific material. It does not permit commercial exploitation or the creation of derivative works without specific permission. To view a copy of this license, visit:
https://creativecommons.org/licenses/by-nc-nd/4.0/.
The publication fee is charged on acceptance of the article and should be paid within 30 days by credit card by the author, funding agency, or institution.
Payment must be received in full for the article to be published OA. Any additional standard publication charges will also apply.
Please find FAQ for OA at http://links.lww.com/LWW-ES/A48.

PAGE PROOFS AND CORRECTIONS

The corresponding author will receive electronic page proofs to check the typeset article before publication. Portable document format (PDF) files of the typeset pages and
support documents (eg, reprint order form) will be sent to the corresponding author by email. Complete instructions will be provided with the email for downloading and printing
the files and for emailing the corrected page proofs to the editorial office.
It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the
author’s meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material
will be disallowed. The editorial office reserves the right to disallow extensive alterations. Authors may be charged for alterations to the proofs beyond those required to
correct errors or to answer queries. Proofs must be checked carefully and corrections emailed within 24 to 48 hours of receipt, as requested in the cover letter
accompanying the page proofs.

RECOMMENDATIONS
The Journal of UrologyÒ considers statistical review an essential part of the peer review process. Papers with substantive statistics are reviewed by one of our
statistical editors at the R1 stage. As part of the statistical review process the statistical editors use the following 3 sets of guidelines as a framework for review:
1. Guidelines for Reporting of Statistics for Clinical Research in Urology (https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000000001) includes common
statistical reporting errors
2. Guidelines for Reporting of Figures and Tables for Clinical Research in Urology (https://www.auajournals.org/doi/10.1097/JU.0000000000001096) includes journal
requirements for presentation of figures and tables
3. Guidelines for Reporting Observational Research in Urology:
4. The Importance of Clear Reference to Causality (https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000003479) includes a discussion of how to reference
causality

For your paper to pass statistical review, you will need to comply with all guidelines except in the case where there is a compelling scientific reason to do so (see
guideline 1 in the common statistical reporting errors). Manuscripts with deviations from these guidelines should include in the manuscript the scientific rationale
for the deviation. The large majority of statistical review comments can be avoided were the authors to implement these guidelines before submission.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - --

Manuscript Checklist
, 1. Manuscript word count is provided.
, 2. Manuscript does not exceed 2,500 words and 30 references for Original Clinical Article.
, 3. Manuscript does not exceed 3,000 words and 30 references for Translational Research Article.
, 4. Manuscript does not exceed 4,000 words and 50 references for Review Article.
, 5. Manuscript does not exceed 500 words and 5 references for Letter to the Editor.
, 6. JU Forum does not exceed 1,500 words without graphics or 1,200 words with a table or illustration; no more than 10
references; and preferably no more than 3 authors from 2 institutions.
, 7. Historical Article does not exceed 1,200 words with a single table or figure or 1,500 words with no visuals; no more
than 10 references should be listed and no more than three authors should be included in the byline.
, 8. No more than 10 illustrations submitted.
, 9. Abbreviations are defined in the manuscript text, and are used consistently throughout.
, 10. Generic names are used for all drugs. Trade names are avoided.
, 11. Normal laboratory values are provided in parentheses when first used.
, 12. Research or project support/funding is noted.
, 13. Institutional Review Board approval of study is indicated.
, 14. Registration number of clinical trial provided.
, 15. References are accurate, complete, and in numerical order as they appear in the text, with all authors listed if 6 or fewer,
or the first 3 authors and "et al" if more than 6.
, 16. A corresponding author and complete address, telephone number, and email address are provided.
, 17. Written permission from publishers to reproduce or adapt previously published illustrations or tables is included.
, 18. Analytical reporting checklist completed.
, 19. Gender and minorities are identified in collection and analyses of data.
 INFORMATION FOR AUTHORS 575

, 20. Abbreviations for human genes are written in italicized capital letters and protein products are written in capital
letters and are not italicized, and are consistent throughout.
, 21. Abbreviations for animal genes are written in italics with only the first letter capitalized, and protein products are
written with only the first letter capitalized and are not italicized, and are consistent throughout.
, 22. Name of validated system used for reporting complications/outcomes provided.